Literature DB >> 16868183

The regulator of G protein signaling domain of axin selectively interacts with Galpha12 but not Galpha13.

Laura N Stemmle1, Timothy A Fields, Patrick J Casey.   

Abstract

Axin, a negative regulator of the Wnt signaling pathway, contains a canonical regulator of G protein signaling (RGS) core domain. Herein, we demonstrate both in vitro and in cells that this domain interacts with the alpha subunit of the heterotrimeric G protein G12 but not with the closely related Galpha13 or with several other heterotrimeric G proteins. Axin preferentially binds the activated form of Galpha12, a behavior consistent with other RGS proteins. However, unlike other RGS proteins, that of axin (axinRGS) does not affect intrinsic GTP hydrolysis by Galpha12. Despite its inability to act as a GTPase-activating protein, we demonstrate that in cells, axinRGS can compete for Galpha12 binding with the RGS domain of p115RhoGEF, a known G12-interacting protein that links G12 signaling to activation of the small G protein Rho. Moreover, ectopic expression of axinRGS specifically inhibits Galpha12-directed activation of the Rho pathway in MDA-MB 231 breast cancer cells. These findings establish that the RGS domain of axin is able to directly interact with the alpha subunit of heterotrimeric G protein G12 and provide a unique tool to interdict Galpha12-mediated signaling processes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16868183     DOI: 10.1124/mol.106.023705

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  18 in total

Review 1.  From individual Wnt pathways towards a Wnt signalling network.

Authors:  Hans A Kestler; Michael Kühl
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-04-12       Impact factor: 6.237

Review 2.  Role of G12 proteins in oncogenesis and metastasis.

Authors:  Juhi Juneja; Patrick J Casey
Journal:  Br J Pharmacol       Date:  2009-04-30       Impact factor: 8.739

Review 3.  Regulators of G Protein Signaling in Analgesia and Addiction.

Authors:  Farhana Sakloth; Claire Polizu; Feodora Bertherat; Venetia Zachariou
Journal:  Mol Pharmacol       Date:  2020-05-30       Impact factor: 4.436

4.  Identification of polycystin-1 and Gα12 binding regions necessary for regulation of apoptosis.

Authors:  Wanfeng Yu; Benjamin J Ritchie; Xuefeng Su; Jing Zhou; Thomas E Meigs; Bradley M Denker
Journal:  Cell Signal       Date:  2010-09-17       Impact factor: 4.315

5.  Suppression of RGSz1 function optimizes the actions of opioid analgesics by mechanisms that involve the Wnt/β-catenin pathway.

Authors:  Sevasti Gaspari; Immanuel Purushothaman; Valeria Cogliani; Farhana Sakloth; Rachael L Neve; David Howland; Robert H Ring; Elliott M Ross; Li Shen; Venetia Zachariou
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-12       Impact factor: 11.205

Review 6.  Heterotrimeric G protein signaling in polycystic kidney disease.

Authors:  Taketsugu Hama; Frank Park
Journal:  Physiol Genomics       Date:  2016-05-13       Impact factor: 3.107

7.  Endothelial nitric oxide synthase inhibits G12/13 and rho-kinase activated by the angiotensin II type-1 receptor: implication in vascular migration.

Authors:  Hiroyuki Suzuki; Keita Kimura; Heigoro Shirai; Kunie Eguchi; Sadaharu Higuchi; Akinari Hinoki; Kazuhiro Ishimaru; Eugen Brailoiu; Danny N Dhanasekaran; Laura N Stemmle; Timothy A Fields; Gerald D Frank; Michael V Autieri; Satoru Eguchi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-12-18       Impact factor: 8.311

Review 8.  Regulation of RhoGEF proteins by G12/13-coupled receptors.

Authors:  Sandra Siehler
Journal:  Br J Pharmacol       Date:  2009-02-18       Impact factor: 8.739

9.  Rho GTPase activity modulates Wnt3a/beta-catenin signaling.

Authors:  Jessica Rossol-Allison; Laura N Stemmle; Katherine I Swenson-Fields; Patrick Kelly; Patrick E Fields; Shannon J McCall; Patrick J Casey; Timothy A Fields
Journal:  Cell Signal       Date:  2009-05-29       Impact factor: 4.315

Review 10.  WNT/Frizzled signalling: receptor-ligand selectivity with focus on FZD-G protein signalling and its physiological relevance: IUPHAR Review 3.

Authors:  J P Dijksterhuis; J Petersen; G Schulte
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.